Resistance to chemotherapy is believed to cause treatment failure of the patient cancer. Secang (Caesalpinia sappan L.) has been proven to possess anticancer activity on some cancer cell lines. The aimed of this study to develop ethanolic extract of secang wood (EES) as chemosensitizing agent through apoptotic induction on breast cancer MCF-7 cells. Extraction of secang was done by using maceration with 70 % ethanol. Single and combinatorial treatment of EES and doxorubicin on MCF-7 breast cancer cells were analyzed by using MTT assay to determine the IC50 value and combination index (CI) to evaluate the combinatorial effect. Apoptosis was analyzed with flowcytometry (annexin V). EES showed a dose-dependent cytotoxicity (IC50 value of 37 µg/ml), while combinatorial treatment showed that 7 concentrations was found to be synergist with doxorubicin on MCF-7 cells. Combinatorial treatment also triggered apoptotic instead of single treatment. Based on this result, we conclude that ethanolic extract of secang wood is potential as chemosensitizing agent in breast cancer.
INTRODUCTION
Doxorubicin is one of the primary chemotherapeutic agents for breast cancer treatment. Medical report by Rumah Sakit Kanker Dharmais stated that in 2007 breast cancer shows the highest incidence compared to another cancer types (Anonymous, 2009) . The main problem of clinical systemic chemotherapy are its toxicity towards normal tissues and suppression of the immune system (Wattanapitayakul et al., 2005) , and occurrence of resistance (Mechetner et al., 1998) . Resistance to chemotherapy is believed to cause treatment failure of the patient. One promising approach to solve this problem is the application of chemosensitizing agent in cancer therapy.
Potent agent which can be used as chemosensitizing agent together with doxorubicin are phytochemical substances, rendering to the fact that there are huge number of substances found in plants that are potential against cancer (Gibbs, 2000) , such as homoisoflavonoid namely brazilin, brazilien, 4-O-methylsappanol, protosappanin A, and caesalpin J which found in secang wood (Lim et al.,1997) . It was suspected to have anticancer effect. Therefore, further study on its potential as co-chemotherapeutic agent needs to be conducted.
This study aimed to observe cytotoxic effect of ethanolic extract of secang wood (EES) single or in combination with doxorubicin, analyzed by using MTT assay. Combinatorial treatment of EES and doxorubicin were applied in order to increase the cytotoxicity of doxorubicin on MCF-7 cells, allowing the use of lower dose of the chemotherapeutic agent giving less toxicity on normal tissues.
MATERIALS AND METHODS

Extraction
Secang woods were collected from Yogyakarta, Indonesia which then determined Department of Pharmaceutical Biology, Faculty of Pharmacy UGM. Dried powder was then extracted by maceration for 5 days with 70% ethanol. Collected filtrate was concentrated using rotary evaporator (Heidolph WB2000).
Cell culture
MCF-7 cells are collection of Cancer Chemoprevention Research Center (CCRC), Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia. The cell was a gift from Prof. Kawaichi, Nara Institute of Science and Technology (NAIST), Japan. Dulbecco's Modified Eagle Medium (DMEM) powder (Gibco) containing 10%v/v Fetal Bovine Serum (FBS) (Gibco), and 10,000 units/ml Penicillin-10,000 μg/ml Streptomycin (Gibco) were used for culture medium. Cells were prepared using 0.25% Tripsin EDTA (Gibco).
Cytotoxicity assay
MTT cytotoxicity assay was used to examine the effect of ethanolic extract of secang wood on MCF 7 cells, either single or in combination with doxorubicin. Cells were distributed to 96-well plate (Nunc) with the density of 5x10 3 cells/well and incubated in 37˚C with 5% CO 2 for 24 hours. For the cytotoxicity assay of ethanolic extract of secang wood, a serial concentration of ethanolic extract of secang wood was diluted on DMEM with DMSO (Sigma) as cosolvent, to get IC 50 value. In combinatorial assay, concentration of about 1/12, 1/8, 1/4, and 3/8 IC 50 were used for both EES and doxorubicin. After 24 hours incubation, 3-
(MTT) (Sigma) was added, followed by 4 hours incubation. Then 10%v/v SDS in 0.1N HCl (Merck) as stopper reagent was added. Plate was then kept with protection from light overnight, continued with absorbance measurement (λ 595 nm) using ELISA reader (Bio-Rad). IC 50 value, a concentration which inhibits 50% cell population, was calculated from linear regression of log concentration versus cells viability.
Apoptotic Induction
Cells (5x10 4 cells/well) were transfered to 6-well plate (Iwaki) and incubated for 24 hours (37°C 5 % CO 2 condition). Cells were treated by EES, doxorubicin, and their combination, and then incubated for 15 hours. Then, cells were centrifugated and added by 100 annexin V-FITC which was diluted in binding buffer. Cells were incubated for 15 minutes and analyzed with flowcytometry λ 488 nm.
Analysis
Combinatorial Assay. Combinatorial treatment was evaluated by calculating Combination Index (CI) value (Reynolds and Maurer, 2005) , which has the formula as follows. Table I . 
RESULTS AND DISCUSSION
In this study we explored the effect of EES single and in combination with doxorubicin on cytotoxicity, and apoptotic induction of MCF-7 breast cancer cells. Secang (Caesalpinia sappan L.) had been proved to have cytotoxic and antiproliferative effect against several cancer cell lines such as HepG2, MDA-MB-231 dan MCF-7, A549 cells (Yen et al., 2010) . Our study showed that single treatment of EES show cytotoxic effect on MCF-7 with IC 50 37 μg/ml (Fig. 1) . According to Ueda et al. (2000) , IC 50 value less than 100 µg/ml shows that related agent has a potent cytotoxicity. Observation of cell morphology after treatment was also done, shown in Fig. 2 and 3 . Increasing concentration of EES was followed by the increasing number of dead cells, quantitatively (Fig. 1) .
Previous study showed that doxorubicin showed strong cytotoxic effect on MCF-7 breast cancer cell lines with IC 50 value 400 µM (Hermawan et al., 2010) . This is due to the characteristic of MCF-7 which is resistant to doxorubicin by overexpressing anti-apoptotic protein Bcl-2 and Pglycoprotein efflux pump (Davis et al., 2003) . To increase the sensitivity of MCF-7 cells towards doxorubicin, we combined doxorubicin with EES.
Our results showed that 7 combinatorial concentration EES and doxorubicin gave synergistic which had CI under 0.9 (Reynolds and Maurer, 2005 (Table  II) . Combination of EES and doxorubicin (18 µg/ml -25 nM) showed higher inhibition of proliferation than single treatment in MCF-7 cells (Fig. 2(A) ). Observation of cell morphology after treatment was also done, shown in Fig. 2(B-E) . This result suggested that this combination give synergistic effect on MCF-7 cells. This synergistic effect is occured due to apoptotic induction and/or cell cycle modulation. We next investigated whether the EES induced apoptosis on MCF-7 cells. The results from cytotoxic assay of EES and doxorubicin were parallel with apoptotic assay using flowcytometry-annexin V-FITC. Combinatorial treatment increased the death cells caused by apoptosis (Fig.3) . Single treatment of EES showed cytotoxic effect and the combination with doxorubicin increased cytotoxicity of doxorubicin in MCF-7 cells. Single treatment of EES did not induce apoptotic, but the combination with doxorubicin increased apoptosis induction of doxorubicin in MCF-7 cells. This result indicated that synergist effect of EES and doxorubicin was through apoptotic induction.
The increased cytotoxic of doxorubicin by EES probably due to upregulation of p53 and inhibition of Bcl-2. Doxorubicin induces DNA damage and triggers the apoptotic pathway or DNA repair depend on the degree of DNA. In the cells with wild type p53 e.g. MCF-7 cells, upregulation of p53 could increase apoptosis induction or G2/M arrest. Previous study mentioned chloroform extract of secang induced expression of p53 on HNSCC31 cells and HNSCC4 cells (head and neck cancer cell line) (Kim et al., 2005 (Zhong et al., 2009) . Our results is similar to the previous study, but the mechanism need to be explored more details in MCF-7 cells.
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